Elaine R. Mardis - Jan 5, 2022 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Jan 5, 2022
Transactions value $
$0
Form type
4
Date filed
1/6/2022, 07:22 PM
Next filing
May 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Stock Option (Right to Buy) Award $0 +40K $0.00 40K Jan 5, 2022 Common Stock 40K $9.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3rd of the option shares vest and become exercisable on January 5, 2023 with the remaining option shares vesting in 24 equal monthly installments thereafter.